163 related articles for article (PubMed ID: 3739914)
1. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
[TBL] [Abstract][Full Text] [Related]
2. Effect of excision of ventricular myocardium on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia.
Denniss AR; Johnson DC; Richards DA; Ross DL; Uther JB
Am J Cardiol; 1987 Mar; 59(6):591-5. PubMed ID: 3825899
[TBL] [Abstract][Full Text] [Related]
3. Changes in ventricular activation time on the signal-averaged electrocardiogram in the first year after acute myocardial infarction.
Denniss AR; Ross DL; Richards DA; Uther JB
Am J Cardiol; 1987 Sep; 60(7):580-3. PubMed ID: 3630941
[TBL] [Abstract][Full Text] [Related]
4. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Kasanuki H; Ohnishi S; Hirosawa K
Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
6. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction.
Denniss AR; Ross DL; Cody DV; Russell PA; Young AA; Richards DA; Uther JB
Eur Heart J; 1988 Jul; 9(7):746-57. PubMed ID: 3169044
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
11. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
Reiter MJ; Easley AR; Mann DE
Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
[TBL] [Abstract][Full Text] [Related]
14. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction.
Denniss AR; Richards DA; Cody DV; Russell PA; Young AA; Cooper MJ; Ross DL; Uther JB
Circulation; 1986 Oct; 74(4):731-45. PubMed ID: 3757187
[TBL] [Abstract][Full Text] [Related]
19. Ectopic ventricular tachycardia sensitive to calcium antagonists in acute myocardial infarction in dogs.
Miyazaki T; Ogawa S; Sakurai K; Mori H; Yamazaki H; Nakamura Y
Am J Cardiol; 1985 Apr; 55(8):1085-90. PubMed ID: 3984871
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
